Why Novavax is different to other vaccines and some Australians have 'held out' for it

The Novavax COVID-19 vaccine has been provisionally approved by Australia after showing promising results in clinical trials. With more than 90 per cent of the country now vaccinated, there are hopes its approval will convince the remaining vaccine-hesitant few to finally get jabbed.

Novavax illustration Source: SBS News